Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01129401 · ClinicalTrials.gov registry record · Phase 1

Stonewall Treatment Evaluation Project

A Phase 1 study, sponsored by University of California, San Francisco.

Completed
Registry status
Phase 1
Development phase
150
Enrollment target

NCT01129401 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 150 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01129401, a Phase 1 study, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
Phase 1
Development phase
150 participants
Enrollment target

Study Summary

This treatment outcome evaluation of the Stonewall Project will recruit 150 participants to complete a face-to-face assessment visit at baseline, 3-month follow-up, and 6-month follow-up to examine treatment outcome with respect to HIV risk and substance use.

Interventions

  • BEHAVIORAL Stonewall Project

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2010-03
Est. Completion 2014-05
Phase Phase 1

What the Registry Record Tells You About NCT01129401

The ClinicalTrials.gov registry entry for NCT01129401 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stonewall Project is the first listed.

NCT01129401 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01129401 about?

NCT01129401 is a clinical study titled "Stonewall Treatment Evaluation Project". This treatment outcome evaluation of the Stonewall Project will recruit 150 participants to complete a face-to-face assessment visit at baseline, 3-month follow-up, and 6-month follow-up to examine treatment outcome with respect to HIV risk and substance use.

What is the current status of trial NCT01129401?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 150 participants. The study started on 2010-03. Estimated completion is 2014-05.

What interventions are being tested in trial NCT01129401?

The interventions under investigation include: Stonewall Project (BEHAVIORAL).

Who is sponsoring clinical trial NCT01129401?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.